Compassionate Use of Pozelimab
NCT05232110
·
clinicaltrials.gov ↗
APPROVED_FOR_MARKETING
Status
INDUSTRY
Sponsor class
Conditions
CD55-deficient Protein-losing Enteropathy
Interventions
DRUG:
Pozelimab
Sponsor
Regeneron Pharmaceuticals